These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


816 related items for PubMed ID: 16571636

  • 1. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
    Salmi TT, Collin P, Korponay-Szabó IR, Laurila K, Partanen J, Huhtala H, Király R, Lorand L, Reunala T, Mäki M, Kaukinen K.
    Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
    [Abstract] [Full Text] [Related]

  • 2. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K, Peräaho M, Collin P, Partanen J, Woolley N, Kaartinen T, Nuutinen T, Halttunen T, Mäki M, Korponay-Szabo I.
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
    Koskinen O, Collin P, Korponay-Szabo I, Salmi T, Iltanen S, Haimila K, Partanen J, Mäki M, Kaukinen K.
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
    Koskinen O, Collin P, Lindfors K, Laurila K, Mäki M, Kaukinen K.
    J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
    [Abstract] [Full Text] [Related]

  • 6. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease.
    Koskinen O, Lindfors K, Collin P, Peräaho M, Laurila K, Woolley N, Partanen J, Mäki M, Kaukinen K.
    Dig Liver Dis; 2010 Oct; 42(10):692-7. PubMed ID: 20409763
    [Abstract] [Full Text] [Related]

  • 7. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
    Koskinen O, Villanen M, Korponay-Szabo I, Lindfors K, Mäki M, Kaukinen K.
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
    [Abstract] [Full Text] [Related]

  • 8. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease.
    Salmi TT, Collin P, Järvinen O, Haimila K, Partanen J, Laurila K, Korponay-Szabo IR, Huhtala H, Reunala T, Mäki M, Kaukinen K.
    Aliment Pharmacol Ther; 2006 Aug 01; 24(3):541-52. PubMed ID: 16886921
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective antibody case finding of coeliac disease in type-1 diabetes children: need of biopsy revisited.
    Popp A, Mihu M, Munteanu M, Ene A, Dutescu M, Colcer F, Raducanu D, Laurila K, Anca I, Mäki M.
    Acta Paediatr; 2013 Mar 01; 102(3):e102-6. PubMed ID: 23211000
    [Abstract] [Full Text] [Related]

  • 11. Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.
    Maglio M, Tosco A, Paparo F, Auricchio R, Granata V, Colicchio B, Indolfi V, Miele E, Troncone R.
    J Pediatr Gastroenterol Nutr; 2010 Jan 01; 50(1):43-8. PubMed ID: 19934769
    [Abstract] [Full Text] [Related]

  • 12. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M, Koskinen O, Kurppa K, Laurila K, Saavalainen P, Salmi T, Ilus T, Huhtala H, Kaukinen K, Lindfors K.
    BMC Immunol; 2018 Dec 06; 19(1):36. PubMed ID: 30522434
    [Abstract] [Full Text] [Related]

  • 13. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
    Salmi TT, Hervonen K, Laurila K, Collin P, Mäki M, Koskinen O, Huhtala H, Kaukinen K, Reunala T.
    Acta Derm Venereol; 2014 Jul 06; 94(4):393-7. PubMed ID: 24352382
    [Abstract] [Full Text] [Related]

  • 14. Altered small-bowel mucosal vascular network in untreated coeliac disease.
    Myrsky E, Syrjänen M, Korponay-Szabo IR, Mäki M, Kaukinen K, Lindfors K.
    Scand J Gastroenterol; 2009 Jul 06; 44(2):162-7. PubMed ID: 18985542
    [Abstract] [Full Text] [Related]

  • 15. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM, Lindfors K, Korponay-Szabo IR, Lohi O, Saavalainen P, Partanen J, Haimila K, Wieser H, Mäki M, Kaukinen K.
    BMC Immunol; 2008 Feb 29; 9():6. PubMed ID: 18312620
    [Abstract] [Full Text] [Related]

  • 16. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.
    Korponay-Szabó IR, Halttunen T, Szalai Z, Laurila K, Király R, Kovács JB, Fésüs L, Mäki M.
    Gut; 2004 May 29; 53(5):641-8. PubMed ID: 15082580
    [Abstract] [Full Text] [Related]

  • 17. Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues.
    Korponay-Szabó IR, Laurila K, Szondy Z, Halttunen T, Szalai Z, Dahlbom I, Rantala I, Kovács JB, Fésüs L, Mäki M.
    Gut; 2003 Feb 29; 52(2):199-204. PubMed ID: 12524400
    [Abstract] [Full Text] [Related]

  • 18. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
    Akbari MR, Mohammadkhani A, Fakheri H, Javad Zahedi M, Shahbazkhani B, Nouraie M, Sotoudeh M, Shakeri R, Malekzadeh R.
    Eur J Gastroenterol Hepatol; 2006 Nov 29; 18(11):1181-6. PubMed ID: 17033439
    [Abstract] [Full Text] [Related]

  • 19. Intestinal anti-transglutaminase 2 immunoglobulin A deposits in children at risk for coeliac disease (CD): data from the PreventCD study.
    Borrelli M, Maglio M, Korponay-Szabó IR, Vass V, Mearin ML, Meijer C, Niv-Drori H, Ribes-Koninckx C, Roca M, Shamir R, Troncone R, Auricchio R.
    Clin Exp Immunol; 2018 Mar 29; 191(3):311-317. PubMed ID: 29114847
    [Abstract] [Full Text] [Related]

  • 20. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K, Mäki M, Kaukinen K.
    Autoimmun Rev; 2010 Sep 29; 9(11):744-9. PubMed ID: 20547248
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 41.